Cargando…
Absence of lung fibrosis after a single pulmonary delivery of lipid nanocapsules in rats
Lipid nanocapsules (LNCs) are potential drug carriers for pulmonary delivery since they can be nebulized without any structural or functional changes, and the aerosols produced are highly compatible with pulmonary drug delivery in human beings. The alveolar surface tension, in vitro cytotoxicity, bi...
Autores principales: | Hureaux, José, Lacoeuille, Franck, Lagarce, Frédéric, Rousselet, Marie-Christine, Contini, Aurélien, Saulnier, Patrick, Benoit, Jean-Pierre, Urban, Thierry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687496/ https://www.ncbi.nlm.nih.gov/pubmed/29184405 http://dx.doi.org/10.2147/IJN.S146740 |
Ejemplares similares
-
Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery
por: Groo, Anne-Claire, et al.
Publicado: (2013) -
Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study
por: Ramadan, Alyaa, et al.
Publicado: (2011) -
Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide
por: Messaoudi, Khaled, et al.
Publicado: (2014) -
Lipid Nanocapsules Loaded with Rhenium-188 Reduce Tumor Progression in a Rat Hepatocellular Carcinoma Model
por: Vanpouille-Box, Claire, et al.
Publicado: (2011) -
Di-O-lauroyl-decitabine-lipid nanocapsules: toward extending decitabine activity
por: Briot, Thomas, et al.
Publicado: (2019)